![]() |
The large U.S. agbio and medical devices companies are increasingly outsourcing innovation and new product development to smaller, more nimble companies. This opportunity drives our investment goal of funding and migrating into the U.S. and other major markets a pipeline of new products for acquisition by these large players. This cycle of investment and attractive returns to investors will continue for at least the next 10-15 years.
The global agbio (agricultural biotechnology) market is experiencing explosive growth in both developing and developed nations. The agbio industry is technologically diverse and addresses global problems that extend far beyond agriculture...
Medical devices are defined as technology (other than medicine) used to treat human conditions. Well known examples include the heart pacemaker, artificial joints and stents to unblock arteries. Medical Devices include an array of non-drug technologies that seek to enhance the quality of life with demand being driven by the baby boomers...